Inhibitor of HIV-1 reverse transcriptase:: N′-(5-bromo-2-pyridyl)-N-[2-(2,5-di-methoxyphenyl)ethyl] thiourea

被引：22
|
作者：
Sudbeck, EA
Jennissen, JD
Venkatachalam, TK
Ucukun, FM
机构：
[1] Hughes Inst, Dept Biol Struct, Drug Discovery Program, St Paul, MN USA
[2] Hughes Inst, Dept Chem, Drug Discovery Program, St Paul, MN USA
[3] Hughes Inst, Dept Virol, Drug Discovery Program, St Paul, MN USA
来源：
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS | 1999年 / 55卷
关键词：
D O I：
10.1107/S0108270199012044
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The crystal structure of the title compound, C16H18BrN3O2S (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase, revealed an intramolecular hydrogen bond between a thiourea N atom and the pyridyl-N atom [N-H ... N = 2.671(3) Angstrom, graph-set motif S-1(1)(6)] that imparts a more rigid conformation to the molecule. A second hydrogen bond between a thiourea N atom and the thiocarbonyl-S atom [N-H-2... S = 3.403(2) Angstrom, graph-set motif R-2(2)(8)] was observed between inversion-related molecules of HI-236. The first-level hydrogen-bond graph-set notation for HI-236 was determined to be St(6)R-2(2)(8).
引用
收藏
页码：2122 / 2124
页数：3
相关论文
共 50 条
  • [41] N-(3-Bromo-5-methyl-2-pyridyl)-4-methylbenzenesulfonamide
    Peng, Ming
    Luo, Youfu
    Chen, Lijuan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O205 - U2866
  • [42] Synthesis, biological evaluation, and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles targeted at the HIV-1 reverse transcriptase
    Silvestri, R
    Artico, M
    De Martino, G
    Ragno, R
    Massa, S
    Loddo, R
    Murgioni, C
    Loi, AG
    La Colla, P
    Pani, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1567 - 1576
  • [43] N-[2-(5-Bromo-2-morpholin-4-ylpyrimidin-4-ylsulfanyl)-4-methoxyphenyl]-2,4,6-trimethylbenzenesulfonamide
    Kumar, Mohan
    Mallesha, L.
    Sridhar, M. A.
    Kapoor, Kamini
    Gupta, Vivek K.
    Kant, Rajni
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O3061 - +
  • [44] Bis{μ-1,3-bis[2-(5-bromo-2-oxidobenzylideneamino)ethyl]-2-(5-bromo-2-oxidophenyl)-1,3-imidazolidine}dineodymium(III) N,N-dimethylformamide hexasolvate
    Xie, Qing-Fan
    Huang, Miao-Ling
    Chen, Yan-Min
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : M1660 - U1401
  • [45] 1-[1-(Hydroxyimino)ethyl]-N-(2-methoxyphenyl)cyclopropanecarboxamide
    Wang, Jun-Ling
    Meng, Shuang-Ming
    Tian, Mao-Zhong
    Feng, Feng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : 01618 - U2806
  • [46] N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1
    Uckun, FM
    Pendergrass, S
    Maher, D
    Zhu, D
    Tuel-Ahlgren, L
    Mao, C
    Venkatachalam, TK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (24) : 3411 - 3416
  • [47] 2',5'-OLIGOADENYLATE MEDIATED INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE
    SOBOL, RW
    WILSON, SH
    KUMAR, A
    LEE, BJ
    HATFIELD, DL
    CHARUBALA, R
    PFLEIDERER, W
    SUHADOLNIK, RJ
    FASEB JOURNAL, 1991, 5 (06): : A1556 - A1556
  • [48] Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system
    Panczyk, Katarzyna
    Pytka, Karolina
    Jakubczyk, Magdalena
    Rapacz, Anna
    Salat, Kinga
    Furgala, Anna
    Siwek, Agata
    Gluch-Lutwin, Monika
    Grybos, Anna
    Sloczynska, Karolina
    Pekala, Elzbieta
    Zmudzki, Pawel
    Bucki, Adam
    Kolaczkowski, Marcin
    Zelaszczyk, Dorota
    Marona, Henryk
    Waszkielewicz, Anna M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (11) : 2039 - 2049
  • [49] Synthesis of N-[2-(1-piperidinyl)ethyl]benzamides
    Fujisaki, F
    Abe, N
    Sumoto, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2002, 50 (01) : 129 - 132
  • [50] Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N′-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus
    Mao, C
    Sudbeck, EA
    Venkatachalam, TK
    Uckun, FM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (11) : 1593 - 1598
12345